Survey finds antimicrobial resistance important to public, with a high WTP in the UK
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - September 1, 2021 Category: Drugs & Pharmacology Source Type: news

RPS Pharma Scene Podcast out today with Dame Sally Davies
“Please pharmacists round the world help us,” asks Dame Sally Davies, the UK Special Envoy on Antimicrobial Resistance (AMR), and the first special guest on the new RPS Pharma Scene Podcas (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 27, 2021 Category: Drugs & Pharmacology Source Type: news

Resources developed to help reduce the impact of antibiotic resistance
HEE today launches two new videos to help support health and care staff in a variety of settings to understand and prevent the threats posed by antimicrobial resistance. The videos will help health and care staff to: understand the connection between antibiotic use and antibiotic resistance identify their role in optimising antibiotic use and stewardship ensure compliance with national guidance when recommending, prescribing, dispensing and administering antibiotics improve their self-care/safe ty-netting advice to patients on the appropriate use of antibiotics” (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 4, 2021 Category: Consumer Health News Source Type: news

Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey
Survey of 74 TB, gonorrhoea and respiratory tract infection guidelines found relatively few considered resistance at local level, and many did not consider contextual factors necessary for appropriate antimicrobial use. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 3, 2021 Category: Consumer Health News Source Type: news

Mayo Clinic in Florida recognized as Center of Excellence for Antimicrobial Stewardship
JACKSONVILLE, Fla. — Mayo Clinic in Florida has been recognized as an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America (IDSA) ― the only hospital in North Florida to hold that designation. This designation recognizes Mayo Clinic's optimal antimicrobial use and ongoing efforts to combat antimicrobial resistance. "We are honored to receive the IDSA Center of Excellence designation," says Julio Mendez, M.D., chair of Mayo C linic Florida's Antimicrobial Stewardship Program. "It is… (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - August 3, 2021 Category: Hospital Management Source Type: news

SMART breakthrough in detection of SARS-CoV-2 variant in wastewater
(Singapore-MIT Alliance for Research and Technology (SMART)) Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, alongside collaborators from Biobot Analytics, Nanyang Technological University (NTU) and Massachusetts Institute of Technology (MIT), have successfully developed an innovative, open-source molecular detection method that is able to detect and quantify the B.1.1.7 (Alpha) variant of SARS-CoV-2. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 21, 2021 Category: Biology Source Type: news

Antibiotic Resistance Crisis: An Update on Antagonistic Interactions between Probiotics and Methicillin-Resistant Staphylococcus aureus (MRSA)
Antimicrobial resistance (AMR) havoc is a global multifaceted crisis endowing a significant challenge for the successful eradication of devastating pathogens. Methicillin-Resistant Staphylococcus aureus (MRSA) is an enduring superbug involved in causing devastating infections. Although MRSA is a frequent colonizer of human skin, wound, and anterior nares, the intestinal colonization of MRSA has greatly increased the risk of inducing MRSA-associated colitis besides creating a conducive environment for horizontal transfer of resistant genes to commensal microbes. On the other hand, staphylococcal resistance to last-resort an...
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news

Are silver nanoparticles a silver bullet against microbes?
Antimicrobials are used to kill or slow the growth of bacteria, viruses and other microorganisms. They can be in the form of antibiotics, used to treat bodily infections, or as an additive or coating on commercial products used to keep germs at bay. These life-saving tools are essential to preventing and treating infections in humans, animals and plants, but they also pose a global threat to public health when microorganisms develop resistance to them, a concept known as antimicrobial resistance. (Source: World Pharma News)
Source: World Pharma News - July 14, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Are silver nanoparticles a silver bullet against microbes?
(University of Pittsburgh) Antimicrobials are used to kill or slow the growth of bacteria, viruses and other microorganisms. They are essential to preventing and treating infections, but they also pose a global threat to public health when microorganisms develop antimicrobial resistance. A University of Pittsburgh lab studied the mechanisms behind bacterial resistance to silver nanoparticles to determine if their ubiquitous use is a solution to this challenge or if it is perhaps fueling the fire. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 13, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats
NEW BRUNSWICK, N.J., July 9, 2021 – Johnson & Johnson (the Company) today announced the launch of the J&J Centers for Global Health Discovery (J&J Centers), a new, global network of unique research partnerships that will leverage the institutional strengths of Johnson & Johnson and leading academic institutions to accelerate discovery research to address the world’s most pressing global health challenges. The first J&J Satellite Center for Global Health Discovery (Satellite Center) was launched at the London School of Hygiene & Tropical Medicine (LSHTM) at an event co-hosted by Johnson & Jo...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Antimicrobial Resistance Threat Continues During COVID Antimicrobial Resistance Threat Continues During COVID
The COVID-19 pandemic may have temporarily shifted the focus away from fighting antimicrobial resistance for some, but it did not dimmish the urgency.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 2, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic
The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘ One Health ’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security. (Source: University of Bristol news)
Source: University of Bristol news - June 17, 2021 Category: Universities & Medical Training Tags: Health, Research, International; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Bristol Veterinary School, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Schoo Source Type: news

GW4 takes a One Health approach to tackling the antimicrobial resistance pandemic
(University of Bath) The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities -- GW4) formally launch their new 'One Health' antimicrobial resistance research consortium today. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 16, 2021 Category: Infectious Diseases Source Type: news